Trials / Completed
CompletedNCT04837157
Evaluation of the Exoskeleton ATLAS 2030 as Robot-assisted Physical Therapy to Children With Neuromuscular Diseases
Evaluation of the Safety of ATLAS 2030 in the Application of Robot-assisted Physical Therapy to Children With Neuromuscular Diseases Phase I
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- MarsiBionics · Industry
- Sex
- All
- Age
- 3 Years – 14 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the safety, usability and acceptability of a motorized mobility assistance exoskeleton. The protocol explores the use of the motorized device during static and dynamic rehabilitation sessions focused on walking and functional activities, with the expectation of evaluating the safety and usability of the device in the population studied. The protocol has been focused on defining how the device can be used appropriately in this population in a safe and effective manner by rehabilitation specialists. The study also aims to assess the safety of clinical staff who implement the intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Exoskeleton rehabilitation | The participants will perform physical therapy with the ATLSA2030 device, for 90 minutes per session. |
Timeline
- Start date
- 2020-10-15
- Primary completion
- 2020-12-31
- Completion
- 2021-01-31
- First posted
- 2021-04-08
- Last updated
- 2021-04-08
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04837157. Inclusion in this directory is not an endorsement.